Skip to main content
Log in

Celiac disease in Type 1 diabetic children and adults: IgA class transglutaminase autoantibodies as the best screening marker

  • Letter To The Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev 2002, 23: 464–83.

    Article  CAS  PubMed  Google Scholar 

  2. Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 2002, 25: 1117–22.

    Article  PubMed  Google Scholar 

  3. Holmes GKT. Coeliac disease and type 1 diabetes mellitus: the case for screening. Diabet Med 2001, 18: 169–77.

    Article  CAS  PubMed  Google Scholar 

  4. Seissler J, Schott M, Boms S, et al. Autoantibodies to human tissue transglutaminase identify silent coeliac disease in type I diabetes. Diabetologia 1999, 42: 1440–1.

    Article  CAS  PubMed  Google Scholar 

  5. Lazzarotto F, Basso D, Plebani M, et al. Celiac Disease and Type 1 Diabetes. Diabetes Care 2003, 26: 248–9.

    Article  PubMed  Google Scholar 

  6. Meoro A, Chinchilla V, Sánchez J, et al. Transglutaminase autoantibodies as the best screening for celiac disease in spanish type 1 diabetic children and adults. Diabetologia 2001, 44 (Suppl1): A102.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meoro, A., Eleno, I., Sánchez, J. et al. Celiac disease in Type 1 diabetic children and adults: IgA class transglutaminase autoantibodies as the best screening marker. J Endocrinol Invest 28, 864–865 (2005). https://doi.org/10.1007/BF03347582

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347582

Keywords

Navigation